Multicenter Randomized Clinical Trial RSKC001 started

We are pleased to announce the start of the multicenter randomized clinical trial aiming at assessing theranostic-guided corneal cross-linking for treatment of keratoconus. The clinical trial is conducted at three of the major Italian Universities devoted to the treatment of this ocular pathology, which afflicts about 2% of young people globally. For more information contact us at clinicaltrials@regensight.com.